9.2 Pediatric Shock States & Vasoactive / Inotropic Selection
Key Takeaways
- Pediatric septic shock presents predominantly as 'cold shock' (~60–70% of community-acquired pediatric cases), characterized by decreased cardiac output, elevated systemic vascular resistance (SVR), prolonged capillary refill (>2 seconds), and weak peripheral pulses, requiring inotropic support rather than pure vasoconstriction.
- Initial fluid resuscitation mandates the rapid administration of balanced crystalloids (Plasma-Lyte or Lactated Ringer's) in 10–20 mL/kg aliquots over 10–20 minutes, pausing immediately if clinical signs of fluid overload appear (hepatomegaly, pulmonary crackles, worsening work of breathing).
- Epinephrine (0.05–0.3 mcg/kg/min) is the preferred first-line vasoactive agent for cold septic shock and cardiogenic dysfunction, whereas norepinephrine (0.05–0.3 mcg/kg/min) is the first-line choice for warm distributive shock exhibiting low SVR, flash capillary refill, and wide pulse pressure.
- Dopamine is now relegated to a second-line or obsolete status in pediatric septic shock guidelines following randomized trials demonstrating higher 28-day mortality, increased healthcare-associated infections, and erratic receptor pharmacodynamics in young infants.
- Refractory catecholamine-resistant shock warrants prompt initiation of stress-dose hydrocortisone (50–100 mg/m²/day or 1–2 mg/kg/day divided every 6 hours) to treat critical illness-related corticosteroid insufficiency (CIRCI), alongside milrinone (0.25–0.75 mcg/kg/min without bolus) for afterload reduction in persistent low-output states.
9.2 Pediatric Shock States & Vasoactive / Inotropic Selection
Shock is fundamentally defined as an acute failure of the circulatory system to deliver adequate oxygen and metabolic substrates to meet the metabolic demands of tissues ($DO_2 < VO_2$), leading to cellular dysoxia, anaerobic metabolism, lactic acidosis, and organ system failure. In pediatric patients, the physiological reserve and compensatory mechanisms differ profoundly from adults. Pediatric stroke volume is relatively fixed due to non-compliant, immature myocardium containing fewer contractile elements per gram of tissue; cardiac output is therefore almost entirely heart rate-dependent ($CO = HR \times SV$).
Compensated vs. Decompensated Pediatric Shock
Children maintain normal systemic blood pressure through intense compensatory peripheral vasoconstriction and tachycardia long after tissue hypoperfusion has begun. As a result, blood pressure is an exceptionally insensitive marker of early circulatory collapse.
Progression of Pediatric Shock:
[COMPENSATED SHOCK] [DECOMPENSATED SHOCK] [CARDIOPULMONARY ARREST]
- Heart rate: Marked tachycardia - Heart rate: Extreme tachy / brady - Severe bradycardia / Asystole
- Blood pressure: NORMAL - Blood pressure: HYPOTENSION - Pulseless
- Perfusion: Cool, cap refill >2s - Perfusion: Mottled / cyanotic - Apnea / Gasping
- Pulses: Weak peripheral, full core - Pulses: Absent peripheral, thready - Immediate CPR required
- Mentation: Irritable / lethargic - Mentation: Stupor / Coma
- Urine: Oliguria (<1 mL/kg/h) - Urine: Anuria
Blood Pressure Thresholds Defining Hypotension by Age (5th Percentile)
Hypotension in pediatrics represents a late, pre-terminal event. The American Heart Association (AHA) and PALS define the lower limit of normal systolic blood pressure (5th percentile) as:
- Term Neonates (0 to 28 days): $<60 \text{ mmHg}$
- Infants (1 to 12 months): $<70 \text{ mmHg}$
- Children (1 to 10 years): $< [70 + (2 \times \text{age in years})] \text{ mmHg}$
- Example (5-year-old child): $70 + (2 \times 5) = 80 \text{ mmHg}$
- Children >10 years & Adolescents: $<90 \text{ mmHg}$
Categorization of Pediatric Shock States
| Shock Category | Primary Pathophysiology | Key Clinical Manifestations | Primary Pharmacotherapeutic Strategy |
|---|---|---|---|
| Hypovolemic | Inadequate intravascular volume from fluid loss or hemorrhage; reduced preload ($CVP \downarrow, CO \downarrow, SVR \uparrow$) | Dehydration, depressed fontanelle, dry mucous membranes, tachycardia, weak pulses | Balanced crystalloids: 10–20 mL/kg boluses over 10–20 min; PRBCs (10 mL/kg) for hemorrhagic shock. |
| Distributive | Dysregulated vasomotor tone, massive capillary leak, microvascular shunting ($SVR \downarrow$ or variable, $CO$ variable) | Septic shock, anaphylaxis, neurogenic shock; present as Cold Shock (~65%) or Warm Shock (~35%) | Targeted fluid resuscitation, early vasoactive infusions (Epinephrine for cold, Norepinephrine for warm). |
| Cardiogenic | Intrinsic myocardial pump failure with impaired contractility ($CVP \uparrow, CO \downarrow, SVR \uparrow$) | Hepatomegaly, jugular venous distention, pulmonary crackles, gallop rhythm ($S_3$), cardiomegaly | Fluid restriction (5–10 mL/kg boluses with extreme caution); inotropes (Milrinone, low-dose Epinephrine). |
| Obstructive | Extracardiac mechanical barrier to blood flow and ventricular filling ($CVP \uparrow, CO \downarrow$) | Cardiac tamponade, tension pneumothorax, pulmonary embolism, ductal-dependent cardiac lesions | Relieve mechanical obstruction (decompression, pericardiocentesis); Alprostadil (PGE1) for ductal lesions. |
Critical Clinical Entity: Neonatal Ductal-Dependent Congenital Heart Defects
In neonates presenting at 1 to 2 weeks of life with profound, sudden cardiovascular collapse and cardiogenic/obstructive shock, closure of the ductus arteriosus must be presumed. Lesions dependent on systemic blood flow via the ductus include:
- Coarctation of the aorta
- Interrupted aortic arch
- Critical aortic stenosis
- Hypoplastic left heart syndrome (HLHS)
Immediate Pharmacotherapy: Alprostadil (Prostaglandin E1, PGE1) continuous IV infusion initiated at $0.05 \text{ to } 0.1 \text{ mcg/kg/min}$. Once ductal patency is established (demonstrated by equalized upper and lower extremity pulses, improved systemic perfusion, and resolved metabolic acidosis), titrate down to a maintenance rate of $0.01 \text{ to } 0.025 \text{ mcg/kg/min}$.
[!WARNING] PGE1-Induced Apnea: Alprostadil induces sudden central apnea in 10% to 12% of neonates, usually within the first hour of infusion initiation. The clinical team must have endotracheal intubation equipment and emergency airway drugs immediately available at the bedside before starting PGE1.
Hemodynamic Profiles: Cold Shock vs. Warm Shock in Pediatric Sepsis
Unlike adult septic shock, which presents almost universally as hyperdynamic "warm shock" with high cardiac output and profound peripheral vasodilation ($SVR \downarrow$), community-acquired pediatric septic shock presents predominantly as hypodynamic "Cold Shock" in 60% to 70% of cases.
| Hemodynamic Parameter | Cold Shock (~65% of Pediatric Sepsis) | Warm Shock (~35% of Pediatric Sepsis) |
|---|---|---|
| Primary Pathology | Myocardial depression + intense compensatory vasoconstriction | Profound peripheral vasodilation + low vascular tone |
| Cardiac Output / Index | Low ($CI < 3.3 \text{ L/min/m}^2$) | High ($CI > 5.5 \text{ L/min/m}^2$) |
| Systemic Vascular Resistance | High ($SVR \uparrow$) | Low ($SVR \downarrow$) |
| Extremities | Cold, clammy, mottled, pale | Warm, flushed, dry |
| Capillary Refill Time | Prolonged (>2 seconds; often >4–5 seconds) | Flash (<1 second) |
| Peripheral Pulses | Diminished, thready, or absent | Bounding, brisk |
| Pulse Pressure | Narrow ($SBP - DBP \downarrow$, e.g., 82/64 mmHg) | Wide ($SBP - DBP \uparrow$, e.g., 85/35 mmHg) |
| First-Line Vasoactive Agent | Epinephrine (0.05–0.3 mcg/kg/min) | Norepinephrine (0.05–0.3 mcg/kg/min) |
Initial Fluid Resuscitation Protocols & Fluid Overload Risks
Balanced Crystalloids vs. 0.9% Normal Saline
Current pediatric consensus guidelines (Surviving Sepsis Campaign Pediatric Guidelines) strongly recommend balanced crystalloids (e.g., Plasma-Lyte A, Lactated Ringer's) over 0.9% Normal Saline for acute shock resuscitation.
- The Hyperchloremic Acidosis Danger: Normal saline contains 154 mEq/L of chloride, drastically exceeding normal plasma chloride concentrations (98 to 106 mEq/L). Infusing large volumes of 0.9% NaCl induces hyperchloremic metabolic acidosis, triggers renal afferent arteriolar vasoconstriction, lowers renal cortical perfusion, reduces glomerular filtration rate, and significantly increases the incidence of acute kidney injury (AKI).
Fluid Administration Mechanics
- Dosing: Administer 10 to 20 mL/kg aliquots of balanced crystalloid.
- Rate: Infuse rapidly over 10 to 20 minutes via push-pull syringe technique or pressure-bag delivery through the largest gauge vascular access.
- Reassessment Mandate: Perform focused clinical reassessment after each fluid bolus:
- Assess heart rate, capillary refill, mental status, peripheral pulse volume, and urine output.
- Stop Fluid Boluses Immediately if signs of fluid overload or cardiac failure develop:
- Development of new or worsening hepatomegaly (palpate liver edge prior to and following every bolus).
- New bilateral pulmonary crackles (rales) or worsening work of breathing.
- New cardiac gallop rhythm ($S_3$).
Fluid Overload Quantification & Morbidity Thresholds
In pediatric critical care, aggressive fluid administration without physiological clearance results in cumulative fluid overload. Cumulative fluid overload exceeding 10% to 15% independently correlates with a doubling of pediatric ICU mortality, increased days on mechanical ventilation, and escalated needs for continuous renal replacement therapy (CRRT).
Clinical Calculation Example: A 20 kg child has a cumulative 48-hour fluid intake of 5.8 L and total urine/drain output of 3.2 L:
Vasoactive & Inotropic Selection in Fluid-Refractory Shock
When shock signs (hypoperfusion, delayed/flash capillary refill, altered mentation, oliguria) persist despite 40 to 60 mL/kg of fluid resuscitation—or immediately if signs of fluid overload develop—vasoactive infusions must be initiated without delay.
Vasoactive Selection Algorithm for Pediatric Fluid-Refractory Shock:
[Fluid-Refractory Shock]
│
┌─────────────────┴─────────────────┐
▼ ▼
[COLD SHOCK] [WARM SHOCK]
(Low CO, High SVR, Narrow PP) (High CO, Low SVR, Wide PP)
│ │
▼ ▼
[FIRST-LINE: EPINEPHRINE] [FIRST-LINE: NOREPINEPHRINE]
(0.05-0.3 mcg/kg/min) (0.05-0.3 mcg/kg/min)
│ │
Persistent Cold Shock Persistent Warm Shock
│ │
▼ ▼
Add Inodilator: Add Vasoconstrictor:
[MILRINONE] [VASOPRESSIN]
(0.25-0.75 mcg/kg/min, NO bolus) (0.0003-0.002 units/kg/min)
│ │
└─────────────────┬─────────────────┘
│
▼
[Refractory Catecholamine-Resistant Shock]
│
▼
[STRESS-DOSE HYDROCORTISONE]
(50-100 mg/m2/day or 1-2 mg/kg/day q6h)
Detailed Vasoactive Pharmacology Matrix
| Drug | Primary Receptors | Hemodynamic Actions | Clinical Dosing Range | Pediatric Clinical Pearls |
|---|---|---|---|---|
| Epinephrine | $\beta_1, \beta_2$ (low dose);<br>$\alpha_1, \beta_1$ (high dose) | Inotrope, chronotrope, systemic vasoconstrictor at high doses; increases $CO$ and $DO_2$ | 0.05–0.3 mcg/kg/min<br>(Titrated up to 1 mcg/kg/min in severe shock) | First-line for Cold Septic Shock and Cardiogenic Shock. At $\le 0.05$ mcg/kg/min, $\beta_2$ vasodilation predominates; at $>0.1$ mcg/kg/min, $\alpha_1$ vasoconstriction supports diastolic pressure. Stimulates skeletal muscle $\beta_2$ receptors causing transient, benign aerobic hyperlactatemia (distinguish from hypoperfusion lactate). |
| Norepinephrine | $\alpha_1 \gg \beta_1$ | Potent systemic vasoconstriction with modest inotropy; increases $SVR$, increases MAP, improves coronary perfusion | 0.05–0.3 mcg/kg/min<br>(Titrated up to 1 mcg/kg/min) | First-line for Warm Distributive Septic Shock. Effectively restores diastolic blood pressure and vascular tone without inducing excessive tachycardia. |
| Dopamine | $\text{DA}_1$ (1–3);<br>$\beta_1$ (3–10);<br>$\alpha_1$ (>10 mcg/kg/min) | Variable inotropy and vasoconstriction depending on conversion to norepinephrine | 5–20 mcg/kg/min | Relegated to Second-Line. Relies on endogenous conversion to norepinephrine; in neonates and young infants, dopamine clearance is erratic and sympathetic nerve terminals are immature. Pediatric trials (Carcillo et al., Venturini et al.) revealed significantly higher 28-day mortality and infection rates compared to epinephrine. |
| Milrinone | Phosphodiesterase-3 (PDE3) Inhibitor | "Inodilator": positive inotrope, enhances lusitropy (diastolic relaxation), induces systemic & pulmonary vasodilation ($SVR \downarrow, PVR \downarrow$) | Maintenance: 0.25–0.75 mcg/kg/min.<br>(Loading dose of 50 mcg/kg over 30–60 min is OMITTED in shock) | Second-line inotrope for persistent cold shock with high SVR or post-cardiac surgery. Does not depend on $\beta$-adrenergic receptors. Renally cleared (85–90% unchanged): clearance drops dramatically in AKI, expanding half-life from 1.5–2 hours to 6–12+ hours; reduce maintenance infusion by 50% to 75% in renal failure. |
| Vasopressin | $V_{1a}$ vascular receptors | Pure non-adrenergic vasoconstrictor; preserves coronary and cerebral perfusion; restores vascular tone in acidosis | 0.0003–0.002 units/kg/min<br>(0.018–0.12 units/kg/h) | Adjunct for catecholamine-refractory warm shock. Effective when adrenergic receptors are down-regulated or desensitized by severe metabolic acidosis. Monitor for peripheral extravasation necrosis, splanchnic ischemia, and hyponatremia ($V_2$ antidiuretic effect). |
Catecholamine-Refractory Shock & Corticosteroid Therapy
When shock persists despite high-dose catecholamines (e.g., epinephrine or norepinephrine requirements exceeding $>0.3 \text{ to } 0.5 \text{ mcg/kg/min}$), the patient has catecholamine-resistant shock. A major contributor is Critical Illness-Related Corticosteroid Insufficiency (CIRCI), caused by hypothalamic-pituitary-adrenal (HPA) axis exhaustion, blunted corticotropin release, down-regulated glucocorticoid receptors, and suppressed adrenal cortisol synthesis.
Stress-Dose Hydrocortisone Protocol
- Indication: Fluid-refractory, catecholamine-resistant septic shock.
- Dosing Strategies:
- BSA-Based Dosing: 50 to 100 mg/m²/day IV divided every 6 hours.
- Weight-Based Dosing: 1 to 2 mg/kg/day IV divided every 6 hours (up to a maximum of 50 mg per dose or 200 mg/day).
- Mechanism of Action: Hydrocortisone possesses balanced glucocorticoid and mineralocorticoid activity. It upregulates cell-surface $\alpha_1$ and $\beta_1$ adrenergic receptor density, inhibits inducible nitric oxide synthase (iNOS), restores vascular responsiveness to infused catecholamines, and attenuates pathological systemic capillary leak.
- Clinical Weaning: Baseline random cortisol levels and ACTH stimulation tests are not required to initiate therapy in refractory shock. Once vasoactive infusions are successfully weaned and shock resolves, hydrocortisone should be rapidly tapered over 2 to 4 days to prevent secondary immunosuppression, hyperglycemia, and opportunistic infection.
A 3-year-old child (weight 15 kg) with severe meningococcal sepsis has received 60 mL/kg of intravenous Lactated Ringer's over the past 45 minutes. The child remains lethargic with cool, mottled lower extremities, a capillary refill time of 4 seconds, thready peripheral pulses, heart rate 175 beats/min, and blood pressure 72/48 mmHg (mean arterial pressure 56 mmHg). The liver edge is palpable 1 cm below the right costal margin with clear breath sounds. Which vasoactive regimen is the most appropriate first-line pharmacotherapy for this patient's fluid-refractory shock state?
A 7-year-old child (weight 25 kg) is admitted to the pediatric intensive care unit with septic shock secondary to perforated appendicitis. During the first 24 hours of resuscitation, total fluid intake was 4,200 mL and total fluid output was 1,200 mL. The child has developed bilateral rales, tachypnea, and facial edema. What is the patient's percentage of cumulative fluid overload, and how does this impact clinical outcomes?
A 5-month-old infant (weight 6 kg) with acute viral myocarditis presents in cardiogenic shock with low cardiac output, elevated systemic vascular resistance, and pulmonary edema. The team considers initiating milrinone to augment cardiac contractility and reduce ventricular afterload. Serum creatinine is elevated at 1.1 mg/dL (baseline 0.3 mg/dL). Which pharmacological principle must guide the safe administration of milrinone in this infant?